Skip to main content
John Sampson, MD, Neurosurgery, Aurora, CO

John Sampson MD PhD, MBA

Brain & Spinal Tumor


Department Chair, Duke Neurosurgery

Join to View Full Profile
  • 12605 E 16th AveAurora, CO 80045

  • Phone+1 720-848-0000

Dr. Sampson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Large research focus on immunotherapy for high grade glioma.

Education & Training

  • Duke University
    Duke UniversityMBA, 2011
  • Duke University
    Duke UniversityMHSc, 2007
  • Duke University Hospital
    Duke University HospitalResidency, Neurological Surgery, 1991 - 1998
  • Duke University Hospital
    Duke University HospitalInternship, Transitional Year, 1990 - 1991
  • University of Manitoba
    University of ManitobaClass of 1990

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2024 - 2027
  • NC State Medical License
    NC State Medical License 1996 - 2026
  • FL State Medical License
    FL State Medical License 2014 - 2022
  • Neurological Surgery
    American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017

Publications & Presentations

PubMed

Journal Articles

  • Sequestration of T Cells in Bone Marrow in the Setting of Glioblastoma and Other Intracranial Tumors  
    Peter E Fecci, Cosette A Dechant, Robert L Martuza, Karolina Woroniecka, Brian V Nahed, James E Herndon, William T Curry, Aladine A Elsamadicy, John H Sampson, Michael..., Nature
  • Complete response to steroids in dural inflammatory pseudotumor associated with Still's disease  
    Batich, K.B., St. Clair, E.W., McLendon, R.E., Sampson, J.H., J Clin Neurosci, 10/1/2013
  • Isocitrate dehydrogenase 1 (IDH1): What it means to the neurosurgeon  
    Hodges, T.R., Choi, B.D., Bigner, D.D., Yan, H., Sampson, J.H., J Neurosurg, 6/1/2013

Books/Book Chapters

Abstracts/Posters

  • Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.
    Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K.J., Vredenburgh, J.J., Peters, K., Chang, Z., Herndon, J.E., Desjardins, A., Reardon, D.A., Kirkpatrick, J., J Clin Oncol, 1/1/2011
  • Concurrent Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study.
    Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K., Duffy, E., Vredenburgh, J.J., Peters, K.B., Chang, Zheng, Desjardins, A., Kirkpatrick, J.P., ASTRO, Int J Radiat Oncol Biol Phys, 1/1/2011
  • Dendritic cell vaccines targeting cytomegalovirus in glioblastoma.
    Mitchell, D.A., Archer, G.E., Friedman, H.S., Herndon, J.E., Bigner, D.D., Sampson, J.H., 16th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2011

Lectures

  • Chimeric Antigen Receptor (CAR) and Adoptive Cell Transfer 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
  • Novel role for enhancing immunotherapy against pediatric brain tumors using hematopoietic stem cells. 
    San Francisco, CA - 11/21/2013
  • Developmentally regulated antigens for immunologic targeting of medulloblastoma subtypes. 
    San Francisco, CA - 11/21/2013

Other

  • Novel Therapies in the Management of Malignant Brain Tumors: Bevacizumab and Surgery. 
    Chang, S., Sampson, J.H., Aghi, M., Theodosopoulos, P.V., CNS Neurosurger Webinars, Controversies in Neuro-Oncology: An Academic- Community Forum
    1/12/2010
  • Cell-mediated immunotherapy of brain tumors. 
    Sampson, J.H., Doctoral Thesis Defense, Duke University
    12/5/1996

Press Mentions

  • CU Anschutz Innovations and Medtronic Forge Strategic Research Agreement to Drive Healthcare Innovation
    CU Anschutz Innovations and Medtronic Forge Strategic Research Agreement to Drive Healthcare InnovationJanuary 22nd, 2026
  • Historic $40 Million Gift to CU Anschutz Department of Ophthalmology Will Fuel Research and New Therapies
    Historic $40 Million Gift to CU Anschutz Department of Ophthalmology Will Fuel Research and New TherapiesJune 3rd, 2025
  • A Year of Research Momentum and New Opportunities
    A Year of Research Momentum and New OpportunitiesDecember 16th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: